Jpmorgan Chase & CO Kodiak Sciences Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KOD
# of Institutions
103Shares Held
39.8MCall Options Held
7.6KPut Options Held
3.5K-
Baker Bros. Advisors LP New York, NY17.3MShares$67.5 Million0.54% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$15 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$7.67 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$6.46 Million0.0% of portfolio
-
Silverarc Capital Management, LLC1.06MShares$4.14 Million0.71% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $203M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...